nodes	percent_of_prediction	percent_of_DWPC	metapath
Clodronate—Type I hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.0418	0.0939	CcSEcCtD
Clodronate—SLC25A6—Influenza Virus Induced Apoptosis—TGFB1—chronic obstructive pulmonary disease	0.0408	0.14	CbGpPWpGaD
Clodronate—Type I hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.0319	0.0715	CcSEcCtD
Clodronate—SLC25A6—respiratory system—chronic obstructive pulmonary disease	0.0283	0.108	CbGeAlD
Clodronate—SLC25A6—connective tissue—chronic obstructive pulmonary disease	0.0249	0.095	CbGeAlD
Clodronate—SLC25A5—respiratory system—chronic obstructive pulmonary disease	0.0246	0.0939	CbGeAlD
Clodronate—SLC25A6—bronchus—chronic obstructive pulmonary disease	0.0233	0.0888	CbGeAlD
Clodronate—SLC25A5—connective tissue—chronic obstructive pulmonary disease	0.0217	0.0826	CbGeAlD
Clodronate—SLC25A5—bronchus—chronic obstructive pulmonary disease	0.0203	0.0773	CbGeAlD
Clodronate—SLC25A5—smooth muscle tissue—chronic obstructive pulmonary disease	0.0198	0.0756	CbGeAlD
Clodronate—SLC25A6—Host Interactions with Influenza Factors—TGFB1—chronic obstructive pulmonary disease	0.0196	0.0671	CbGpPWpGaD
Clodronate—SLC25A5—Regulation of insulin secretion—RAPGEF3—chronic obstructive pulmonary disease	0.019	0.0651	CbGpPWpGaD
Clodronate—PTGS2—leg—chronic obstructive pulmonary disease	0.0187	0.0712	CbGeAlD
Clodronate—SLC25A5—trachea—chronic obstructive pulmonary disease	0.0182	0.0694	CbGeAlD
Clodronate—SLC25A6—Regulation of insulin secretion—RAPGEF3—chronic obstructive pulmonary disease	0.016	0.0546	CbGpPWpGaD
Clodronate—SLC25A6—lung—chronic obstructive pulmonary disease	0.015	0.0573	CbGeAlD
Clodronate—SLC25A5—Integration of energy metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.015	0.0512	CbGpPWpGaD
Clodronate—SLC25A5—lung—chronic obstructive pulmonary disease	0.0131	0.0499	CbGeAlD
Clodronate—SLC25A6—Integration of energy metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.0125	0.0429	CbGpPWpGaD
Clodronate—SLC25A4—Regulation of insulin secretion—RAPGEF3—chronic obstructive pulmonary disease	0.0125	0.0426	CbGpPWpGaD
Clodronate—SLC25A4—lung—chronic obstructive pulmonary disease	0.0123	0.0467	CbGeAlD
Clodronate—Stomach ache—Salbutamol—chronic obstructive pulmonary disease	0.0109	0.0244	CcSEcCtD
Clodronate—SLC25A4—Integration of energy metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.00979	0.0335	CbGpPWpGaD
Clodronate—Hypercalcaemia—Aminophylline—chronic obstructive pulmonary disease	0.00926	0.0208	CcSEcCtD
Clodronate—SLC25A4—Synaptic Vesicle Pathway—SLC6A4—chronic obstructive pulmonary disease	0.00846	0.0289	CbGpPWpGaD
Clodronate—Foetor hepaticus—Montelukast—chronic obstructive pulmonary disease	0.00845	0.019	CcSEcCtD
Clodronate—Gastrointestinal symptom NOS—Salbutamol—chronic obstructive pulmonary disease	0.00786	0.0177	CcSEcCtD
Clodronate—Renal failure acute—Roflumilast—chronic obstructive pulmonary disease	0.00759	0.017	CcSEcCtD
Clodronate—Extravasation—Aminophylline—chronic obstructive pulmonary disease	0.00737	0.0166	CcSEcCtD
Clodronate—PTGS2—Prostaglandin Synthesis and Regulation—SCGB1A1—chronic obstructive pulmonary disease	0.00735	0.0251	CbGpPWpGaD
Clodronate—Liver disorder—Montelukast—chronic obstructive pulmonary disease	0.00704	0.0158	CcSEcCtD
Clodronate—Pneumonia—Roflumilast—chronic obstructive pulmonary disease	0.00543	0.0122	CcSEcCtD
Clodronate—Hepatocellular injury—Montelukast—chronic obstructive pulmonary disease	0.0048	0.0108	CcSEcCtD
Clodronate—Connective tissue disorder—Roflumilast—chronic obstructive pulmonary disease	0.00476	0.0107	CcSEcCtD
Clodronate—Wheezing—Montelukast—chronic obstructive pulmonary disease	0.00466	0.0105	CcSEcCtD
Clodronate—PTGS2—respiratory system—chronic obstructive pulmonary disease	0.00464	0.0177	CbGeAlD
Clodronate—Wheezing—Salbutamol—chronic obstructive pulmonary disease	0.00449	0.0101	CcSEcCtD
Clodronate—Mediastinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00437	0.0098	CcSEcCtD
Clodronate—Abdominal pain upper—Aminophylline—chronic obstructive pulmonary disease	0.00427	0.00958	CcSEcCtD
Clodronate—Dehydration—Tiotropium—chronic obstructive pulmonary disease	0.0041	0.0092	CcSEcCtD
Clodronate—PTGS2—connective tissue—chronic obstructive pulmonary disease	0.00408	0.0156	CbGeAlD
Clodronate—Angioedema—Roflumilast—chronic obstructive pulmonary disease	0.00385	0.00865	CcSEcCtD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.00383	0.0131	CbGpPWpGaD
Clodronate—PTGS2—bronchus—chronic obstructive pulmonary disease	0.00382	0.0145	CbGeAlD
Clodronate—Dysphagia—Tiotropium—chronic obstructive pulmonary disease	0.00381	0.00855	CcSEcCtD
Clodronate—PTGS2—smooth muscle tissue—chronic obstructive pulmonary disease	0.00373	0.0142	CbGeAlD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Roflumilast—chronic obstructive pulmonary disease	0.00357	0.00801	CcSEcCtD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.00346	0.0118	CbGpPWpGaD
Clodronate—PTGS2—trachea—chronic obstructive pulmonary disease	0.00343	0.0131	CbGeAlD
Clodronate—Infection—Roflumilast—chronic obstructive pulmonary disease	0.00342	0.00768	CcSEcCtD
Clodronate—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.00334	0.00751	CcSEcCtD
Clodronate—Renal failure—Tiotropium—chronic obstructive pulmonary disease	0.00334	0.00749	CcSEcCtD
Clodronate—Dehydration—Arformoterol—chronic obstructive pulmonary disease	0.00331	0.00742	CcSEcCtD
Clodronate—Dehydration—Formoterol—chronic obstructive pulmonary disease	0.00331	0.00742	CcSEcCtD
Clodronate—PTGS2—C-MYB transcription factor network—ELANE—chronic obstructive pulmonary disease	0.00322	0.011	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism of proteins—MUC5AC—chronic obstructive pulmonary disease	0.00318	0.0109	CbGpPWpGaD
Clodronate—Alanine aminotransferase increased—Montelukast—chronic obstructive pulmonary disease	0.00307	0.00689	CcSEcCtD
Clodronate—Abdominal pain upper—Salbutamol—chronic obstructive pulmonary disease	0.00307	0.00688	CcSEcCtD
Clodronate—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.00303	0.0068	CcSEcCtD
Clodronate—Pharyngitis—Tiotropium—chronic obstructive pulmonary disease	0.00302	0.00679	CcSEcCtD
Clodronate—Bronchospasm—Arformoterol—chronic obstructive pulmonary disease	0.00302	0.00678	CcSEcCtD
Clodronate—Bronchospasm—Formoterol—chronic obstructive pulmonary disease	0.00302	0.00678	CcSEcCtD
Clodronate—Urinary tract disorder—Tiotropium—chronic obstructive pulmonary disease	0.00301	0.00676	CcSEcCtD
Clodronate—Connective tissue disorder—Tiotropium—chronic obstructive pulmonary disease	0.00299	0.00672	CcSEcCtD
Clodronate—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.00299	0.00672	CcSEcCtD
Clodronate—Urethral disorder—Tiotropium—chronic obstructive pulmonary disease	0.00299	0.00671	CcSEcCtD
Clodronate—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00297	0.00667	CcSEcCtD
Clodronate—Bronchospasm—Salbutamol—chronic obstructive pulmonary disease	0.00285	0.00641	CcSEcCtD
Clodronate—Mediastinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00275	0.00616	CcSEcCtD
Clodronate—PTGS2—Overview of nanoparticle effects—HMOX1—chronic obstructive pulmonary disease	0.00274	0.00938	CbGpPWpGaD
Clodronate—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00273	0.00614	CcSEcCtD
Clodronate—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00272	0.00611	CcSEcCtD
Clodronate—SLC25A6—Metabolism of proteins—MUC1—chronic obstructive pulmonary disease	0.00271	0.00926	CbGpPWpGaD
Clodronate—Pneumonia—Montelukast—chronic obstructive pulmonary disease	0.0027	0.00606	CcSEcCtD
Clodronate—SLC25A5—Metabolism—APIP—chronic obstructive pulmonary disease	0.00258	0.00884	CbGpPWpGaD
Clodronate—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—chronic obstructive pulmonary disease	0.00249	0.00852	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism of proteins—MUC5AC—chronic obstructive pulmonary disease	0.00249	0.00851	CbGpPWpGaD
Clodronate—PTGS2—lung—chronic obstructive pulmonary disease	0.00246	0.00939	CbGeAlD
Clodronate—Pharyngitis—Formoterol—chronic obstructive pulmonary disease	0.00244	0.00548	CcSEcCtD
Clodronate—Pharyngitis—Arformoterol—chronic obstructive pulmonary disease	0.00244	0.00548	CcSEcCtD
Clodronate—Urinary tract disorder—Arformoterol—chronic obstructive pulmonary disease	0.00243	0.00545	CcSEcCtD
Clodronate—Urinary tract disorder—Formoterol—chronic obstructive pulmonary disease	0.00243	0.00545	CcSEcCtD
Clodronate—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.00242	0.00544	CcSEcCtD
Clodronate—Connective tissue disorder—Arformoterol—chronic obstructive pulmonary disease	0.00242	0.00542	CcSEcCtD
Clodronate—Connective tissue disorder—Formoterol—chronic obstructive pulmonary disease	0.00242	0.00542	CcSEcCtD
Clodronate—Urethral disorder—Formoterol—chronic obstructive pulmonary disease	0.00241	0.00541	CcSEcCtD
Clodronate—Urethral disorder—Arformoterol—chronic obstructive pulmonary disease	0.00241	0.00541	CcSEcCtD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.0024	0.0082	CbGpPWpGaD
Clodronate—Pharyngitis—Montelukast—chronic obstructive pulmonary disease	0.00239	0.00537	CcSEcCtD
Clodronate—Urinary tract disorder—Montelukast—chronic obstructive pulmonary disease	0.00238	0.00534	CcSEcCtD
Clodronate—Connective tissue disorder—Montelukast—chronic obstructive pulmonary disease	0.00237	0.00531	CcSEcCtD
Clodronate—Urethral disorder—Montelukast—chronic obstructive pulmonary disease	0.00236	0.0053	CcSEcCtD
Clodronate—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00236	0.00529	CcSEcCtD
Clodronate—Pharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.0023	0.00517	CcSEcCtD
Clodronate—Urinary tract disorder—Salbutamol—chronic obstructive pulmonary disease	0.00229	0.00515	CcSEcCtD
Clodronate—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	0.00228	0.00512	CcSEcCtD
Clodronate—Infection—Aminophylline—chronic obstructive pulmonary disease	0.00228	0.00512	CcSEcCtD
Clodronate—Urethral disorder—Salbutamol—chronic obstructive pulmonary disease	0.00228	0.00511	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.00224	0.00503	CcSEcCtD
Clodronate—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00222	0.00498	CcSEcCtD
Clodronate—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00222	0.00498	CcSEcCtD
Clodronate—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00219	0.00491	CcSEcCtD
Clodronate—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.00219	0.00491	CcSEcCtD
Clodronate—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00217	0.00487	CcSEcCtD
Clodronate—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00217	0.00487	CcSEcCtD
Clodronate—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00217	0.00487	CcSEcCtD
Clodronate—SLC25A6—Metabolism—APIP—chronic obstructive pulmonary disease	0.00217	0.00741	CbGpPWpGaD
Clodronate—Infection—Tiotropium—chronic obstructive pulmonary disease	0.00215	0.00483	CcSEcCtD
Clodronate—PTGS2—Overview of nanoparticle effects—CRP—chronic obstructive pulmonary disease	0.00215	0.00735	CbGpPWpGaD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.00212	0.00726	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism of proteins—MUC1—chronic obstructive pulmonary disease	0.00211	0.00723	CbGpPWpGaD
Clodronate—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.0021	0.00472	CcSEcCtD
Clodronate—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00209	0.0047	CcSEcCtD
Clodronate—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00204	0.00459	CcSEcCtD
Clodronate—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.00202	0.00454	CcSEcCtD
Clodronate—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.002	0.00448	CcSEcCtD
Clodronate—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.00196	0.00439	CcSEcCtD
Clodronate—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.00196	0.00439	CcSEcCtD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.00195	0.00668	CbGpPWpGaD
Clodronate—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.00192	0.0043	CcSEcCtD
Clodronate—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00191	0.00428	CcSEcCtD
Clodronate—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00187	0.0042	CcSEcCtD
Clodronate—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.00185	0.00415	CcSEcCtD
Clodronate—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00182	0.00409	CcSEcCtD
Clodronate—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00181	0.00407	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.00181	0.00406	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.00181	0.00406	CcSEcCtD
Clodronate—PTGS2—Prostaglandin Synthesis and Regulation—EDN1—chronic obstructive pulmonary disease	0.00179	0.00613	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—SOD3—chronic obstructive pulmonary disease	0.00178	0.0061	CbGpPWpGaD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00177	0.00398	CcSEcCtD
Clodronate—PTGS2—Spinal Cord Injury—MMP12—chronic obstructive pulmonary disease	0.00175	0.00599	CbGpPWpGaD
Clodronate—Infection—Formoterol—chronic obstructive pulmonary disease	0.00174	0.0039	CcSEcCtD
Clodronate—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00174	0.0039	CcSEcCtD
Clodronate—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00172	0.00386	CcSEcCtD
Clodronate—SLC25A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.00171	0.00586	CbGpPWpGaD
Clodronate—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00171	0.00384	CcSEcCtD
Clodronate—Infection—Montelukast—chronic obstructive pulmonary disease	0.0017	0.00382	CcSEcCtD
Clodronate—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.0017	0.00381	CcSEcCtD
Clodronate—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.0017	0.00381	CcSEcCtD
Clodronate—SLC25A4—Metabolism—APIP—chronic obstructive pulmonary disease	0.00169	0.00578	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—GC—chronic obstructive pulmonary disease	0.00167	0.0057	CbGpPWpGaD
Clodronate—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00166	0.00373	CcSEcCtD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—CYP1A2—chronic obstructive pulmonary disease	0.00164	0.00562	CbGpPWpGaD
Clodronate—Infection—Salbutamol—chronic obstructive pulmonary disease	0.00164	0.00368	CcSEcCtD
Clodronate—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00162	0.00365	CcSEcCtD
Clodronate—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.0016	0.0036	CcSEcCtD
Clodronate—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00157	0.00353	CcSEcCtD
Clodronate—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00157	0.00353	CcSEcCtD
Clodronate—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00156	0.0035	CcSEcCtD
Clodronate—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00156	0.0035	CcSEcCtD
Clodronate—SLC25A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.00155	0.0053	CbGpPWpGaD
Clodronate—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00154	0.00345	CcSEcCtD
Clodronate—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00154	0.00345	CcSEcCtD
Clodronate—PTGS2—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00154	0.00526	CbGpPWpGaD
Clodronate—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00153	0.00344	CcSEcCtD
Clodronate—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00151	0.00339	CcSEcCtD
Clodronate—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00151	0.00339	CcSEcCtD
Clodronate—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00151	0.00338	CcSEcCtD
Clodronate—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00148	0.00332	CcSEcCtD
Clodronate—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00147	0.0033	CcSEcCtD
Clodronate—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00146	0.00328	CcSEcCtD
Clodronate—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00145	0.00326	CcSEcCtD
Clodronate—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00145	0.00325	CcSEcCtD
Clodronate—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00145	0.00325	CcSEcCtD
Clodronate—SLC25A6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.00143	0.00491	CbGpPWpGaD
Clodronate—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00143	0.00322	CcSEcCtD
Clodronate—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.00143	0.00322	CcSEcCtD
Clodronate—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00142	0.0032	CcSEcCtD
Clodronate—PTGS2—Overview of nanoparticle effects—CXCL8—chronic obstructive pulmonary disease	0.0014	0.00478	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—GC—chronic obstructive pulmonary disease	0.0014	0.00477	CbGpPWpGaD
Clodronate—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00139	0.00312	CcSEcCtD
Clodronate—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00139	0.00312	CcSEcCtD
Clodronate—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00138	0.0031	CcSEcCtD
Clodronate—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00138	0.0031	CcSEcCtD
Clodronate—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00138	0.00309	CcSEcCtD
Clodronate—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00136	0.00306	CcSEcCtD
Clodronate—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00136	0.00306	CcSEcCtD
Clodronate—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00136	0.00306	CcSEcCtD
Clodronate—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00136	0.00305	CcSEcCtD
Clodronate—SLC25A6—Influenza Infection—TGFB1—chronic obstructive pulmonary disease	0.00136	0.00464	CbGpPWpGaD
Clodronate—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00135	0.00304	CcSEcCtD
Clodronate—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00131	0.00294	CcSEcCtD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.00131	0.00448	CbGpPWpGaD
Clodronate—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.0013	0.00293	CcSEcCtD
Clodronate—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—chronic obstructive pulmonary disease	0.0013	0.00445	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.0013	0.00444	CbGpPWpGaD
Clodronate—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00129	0.00289	CcSEcCtD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.00126	0.0043	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	0.00125	0.00427	CbGpPWpGaD
Clodronate—PTGS2—C-MYB transcription factor network—MPO—chronic obstructive pulmonary disease	0.00124	0.00425	CbGpPWpGaD
Clodronate—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00124	0.00277	CcSEcCtD
Clodronate—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00124	0.00277	CcSEcCtD
Clodronate—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.00123	0.00277	CcSEcCtD
Clodronate—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00121	0.00272	CcSEcCtD
Clodronate—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—chronic obstructive pulmonary disease	0.0012	0.00411	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.0012	0.0041	CbGpPWpGaD
Clodronate—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.0012	0.00268	CcSEcCtD
Clodronate—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.0012	0.00268	CcSEcCtD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.00119	0.00408	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.00119	0.00407	CbGpPWpGaD
Clodronate—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00117	0.00263	CcSEcCtD
Clodronate—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00117	0.00262	CcSEcCtD
Clodronate—PTGS2—S1P1 pathway—VEGFA—chronic obstructive pulmonary disease	0.00113	0.00388	CbGpPWpGaD
Clodronate—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00113	0.00253	CcSEcCtD
Clodronate—SLC25A6—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	0.00112	0.00384	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.00112	0.00383	CbGpPWpGaD
Clodronate—PTGS2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00112	0.00382	CbGpPWpGaD
Clodronate—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00111	0.00249	CcSEcCtD
Clodronate—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00111	0.00249	CcSEcCtD
Clodronate—Rash—Formoterol—chronic obstructive pulmonary disease	0.0011	0.00247	CcSEcCtD
Clodronate—Rash—Arformoterol—chronic obstructive pulmonary disease	0.0011	0.00247	CcSEcCtD
Clodronate—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.0011	0.00247	CcSEcCtD
Clodronate—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.0011	0.00247	CcSEcCtD
Clodronate—SLC25A4—Metabolism—GC—chronic obstructive pulmonary disease	0.00109	0.00373	CbGpPWpGaD
Clodronate—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00109	0.00244	CcSEcCtD
Clodronate—Rash—Montelukast—chronic obstructive pulmonary disease	0.00108	0.00242	CcSEcCtD
Clodronate—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00108	0.00242	CcSEcCtD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.00106	0.00364	CbGpPWpGaD
Clodronate—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.00106	0.00238	CcSEcCtD
Clodronate—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00105	0.00235	CcSEcCtD
Clodronate—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00104	0.00233	CcSEcCtD
Clodronate—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00104	0.00233	CcSEcCtD
Clodronate—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00104	0.00233	CcSEcCtD
Clodronate—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00104	0.00233	CcSEcCtD
Clodronate—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00102	0.00228	CcSEcCtD
Clodronate—SLC25A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.00101	0.00347	CbGpPWpGaD
Clodronate—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00098	0.0022	CcSEcCtD
Clodronate—SLC25A4—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	0.000974	0.00333	CbGpPWpGaD
Clodronate—PTGS2—Overview of nanoparticle effects—TNF—chronic obstructive pulmonary disease	0.000972	0.00333	CbGpPWpGaD
Clodronate—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000951	0.00213	CcSEcCtD
Clodronate—SLC25A5—Disease—HDAC2—chronic obstructive pulmonary disease	0.000913	0.00312	CbGpPWpGaD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	0.000912	0.00312	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.00091	0.00311	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000899	0.00308	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	0.000875	0.00299	CbGpPWpGaD
Clodronate—SLC25A5—Disease—KL—chronic obstructive pulmonary disease	0.000849	0.0029	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000821	0.00281	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	0.000801	0.00274	CbGpPWpGaD
Clodronate—PTGS2—Overview of nanoparticle effects—IL6—chronic obstructive pulmonary disease	0.000784	0.00268	CbGpPWpGaD
Clodronate—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000779	0.00175	CcSEcCtD
Clodronate—PTGS2—C-MYB transcription factor network—GSTM1—chronic obstructive pulmonary disease	0.000777	0.00266	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	0.000775	0.00265	CbGpPWpGaD
Clodronate—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.00077	0.00173	CcSEcCtD
Clodronate—SLC25A6—Disease—HDAC2—chronic obstructive pulmonary disease	0.000765	0.00262	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000762	0.00261	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000756	0.00259	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000753	0.00258	CbGpPWpGaD
Clodronate—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000752	0.00169	CcSEcCtD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	0.000736	0.00252	CbGpPWpGaD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000712	0.0016	CcSEcCtD
Clodronate—SLC25A6—Disease—KL—chronic obstructive pulmonary disease	0.000711	0.00243	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000688	0.00235	CbGpPWpGaD
Clodronate—Infection—Prednisone—chronic obstructive pulmonary disease	0.000683	0.00153	CcSEcCtD
Clodronate—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000668	0.0015	CcSEcCtD
Clodronate—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000655	0.00147	CcSEcCtD
Clodronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—chronic obstructive pulmonary disease	0.000644	0.0022	CbGpPWpGaD
Clodronate—SLC25A5—Disease—ERBB3—chronic obstructive pulmonary disease	0.000636	0.00218	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000634	0.00217	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000631	0.00216	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.00063	0.00215	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	0.000625	0.00214	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000622	0.00213	CbGpPWpGaD
Clodronate—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000605	0.00136	CcSEcCtD
Clodronate—SLC25A4—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	0.000605	0.00207	CbGpPWpGaD
Clodronate—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000598	0.00134	CcSEcCtD
Clodronate—SLC25A4—Disease—HDAC2—chronic obstructive pulmonary disease	0.000597	0.00204	CbGpPWpGaD
Clodronate—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000597	0.00134	CcSEcCtD
Clodronate—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000596	0.00134	CcSEcCtD
Clodronate—SLC25A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000595	0.00204	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000588	0.00201	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000579	0.00198	CbGpPWpGaD
Clodronate—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000562	0.00126	CcSEcCtD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	0.000559	0.00191	CbGpPWpGaD
Clodronate—SLC25A4—Disease—KL—chronic obstructive pulmonary disease	0.000555	0.0019	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000549	0.00188	CbGpPWpGaD
Clodronate—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000546	0.00123	CcSEcCtD
Clodronate—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000544	0.00122	CcSEcCtD
Clodronate—SLC25A4—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000537	0.00184	CbGpPWpGaD
Clodronate—SLC25A6—Disease—ERBB3—chronic obstructive pulmonary disease	0.000533	0.00182	CbGpPWpGaD
Clodronate—SLC25A5—Disease—NOS2—chronic obstructive pulmonary disease	0.00053	0.00182	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000528	0.00181	CbGpPWpGaD
Clodronate—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—chronic obstructive pulmonary disease	0.000526	0.0018	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000521	0.00178	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	0.000515	0.00176	CbGpPWpGaD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	0.000503	0.00172	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000495	0.00169	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—LEP—chronic obstructive pulmonary disease	0.000487	0.00167	CbGpPWpGaD
Clodronate—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000486	0.00109	CcSEcCtD
Clodronate—SLC25A6—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000486	0.00166	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	0.000484	0.00165	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000484	0.00165	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	0.000483	0.00165	CbGpPWpGaD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	0.000479	0.00164	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—TLR4—chronic obstructive pulmonary disease	0.000477	0.00163	CbGpPWpGaD
Clodronate—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.00047	0.00106	CcSEcCtD
Clodronate—SLC25A6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00046	0.00158	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—NOS2—chronic obstructive pulmonary disease	0.000454	0.00155	CbGpPWpGaD
Clodronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—chronic obstructive pulmonary disease	0.000448	0.00153	CbGpPWpGaD
Clodronate—SLC25A5—Disease—SERPINE1—chronic obstructive pulmonary disease	0.000447	0.00153	CbGpPWpGaD
Clodronate—SLC25A6—Disease—NOS2—chronic obstructive pulmonary disease	0.000445	0.00152	CbGpPWpGaD
Clodronate—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000437	0.000981	CcSEcCtD
Clodronate—Rash—Prednisone—chronic obstructive pulmonary disease	0.000434	0.000973	CcSEcCtD
Clodronate—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000433	0.000972	CcSEcCtD
Clodronate—SLC25A5—Disease—NOS3—chronic obstructive pulmonary disease	0.000426	0.00146	CbGpPWpGaD
Clodronate—SLC25A4—Disease—ERBB3—chronic obstructive pulmonary disease	0.000416	0.00142	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000412	0.00141	CbGpPWpGaD
Clodronate—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000408	0.000917	CcSEcCtD
Clodronate—SLC25A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000407	0.00139	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	0.000402	0.00138	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	0.000393	0.00134	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000379	0.0013	CbGpPWpGaD
Clodronate—SLC25A6—Disease—SERPINE1—chronic obstructive pulmonary disease	0.000374	0.00128	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—ALB—chronic obstructive pulmonary disease	0.000373	0.00128	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000359	0.00123	CbGpPWpGaD
Clodronate—SLC25A6—Disease—NOS3—chronic obstructive pulmonary disease	0.000357	0.00122	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000357	0.00122	CbGpPWpGaD
Clodronate—SLC25A4—Disease—NOS2—chronic obstructive pulmonary disease	0.000347	0.00119	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—APIP—chronic obstructive pulmonary disease	0.000334	0.00114	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—CXCL8—chronic obstructive pulmonary disease	0.000324	0.00111	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—ALB—chronic obstructive pulmonary disease	0.000313	0.00107	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—IL1B—chronic obstructive pulmonary disease	0.000311	0.00106	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000299	0.00102	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—MMP9—chronic obstructive pulmonary disease	0.000293	0.001	CbGpPWpGaD
Clodronate—SLC25A4—Disease—SERPINE1—chronic obstructive pulmonary disease	0.000292	0.001	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	0.000285	0.000976	CbGpPWpGaD
Clodronate—SLC25A5—Disease—TGFB1—chronic obstructive pulmonary disease	0.000282	0.000965	CbGpPWpGaD
Clodronate—SLC25A4—Disease—NOS3—chronic obstructive pulmonary disease	0.000279	0.000955	CbGpPWpGaD
Clodronate—SLC25A5—Disease—EGFR—chronic obstructive pulmonary disease	0.000276	0.000946	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—ALB—chronic obstructive pulmonary disease	0.000244	0.000836	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—TGFB1—chronic obstructive pulmonary disease	0.000241	0.000826	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000238	0.000815	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—EGFR—chronic obstructive pulmonary disease	0.000237	0.00081	CbGpPWpGaD
Clodronate—SLC25A6—Disease—TGFB1—chronic obstructive pulmonary disease	0.000236	0.000809	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000234	0.000799	CbGpPWpGaD
Clodronate—SLC25A6—Disease—EGFR—chronic obstructive pulmonary disease	0.000232	0.000793	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	0.00023	0.000787	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—TNF—chronic obstructive pulmonary disease	0.000225	0.000771	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000221	0.000758	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.00022	0.000751	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GC—chronic obstructive pulmonary disease	0.000215	0.000737	CbGpPWpGaD
Clodronate—SLC25A5—Disease—IL6—chronic obstructive pulmonary disease	0.000212	0.000727	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.0002	0.000685	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—TP53—chronic obstructive pulmonary disease	0.000199	0.00068	CbGpPWpGaD
Clodronate—SLC25A4—Disease—TGFB1—chronic obstructive pulmonary disease	0.000184	0.000631	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—IL6—chronic obstructive pulmonary disease	0.000182	0.000623	CbGpPWpGaD
Clodronate—SLC25A4—Disease—EGFR—chronic obstructive pulmonary disease	0.000181	0.000619	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.000179	0.000612	CbGpPWpGaD
Clodronate—SLC25A6—Disease—IL6—chronic obstructive pulmonary disease	0.000178	0.000609	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	0.000164	0.000562	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	0.000161	0.000551	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.00016	0.000546	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	0.000153	0.000525	CbGpPWpGaD
Clodronate—SLC25A4—Disease—IL6—chronic obstructive pulmonary disease	0.000139	0.000476	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	0.000135	0.000463	CbGpPWpGaD
Clodronate—PTGS2—Disease—HDAC2—chronic obstructive pulmonary disease	0.000118	0.000404	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000118	0.000403	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000116	0.000398	CbGpPWpGaD
Clodronate—PTGS2—Disease—KL—chronic obstructive pulmonary disease	0.00011	0.000376	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000108	0.000371	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000106	0.000363	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.78e-05	0.000335	CbGpPWpGaD
Clodronate—PTGS2—Disease—ERBB3—chronic obstructive pulmonary disease	8.23e-05	0.000282	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.15e-05	0.000279	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.04e-05	0.000275	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.49e-05	0.000256	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.1e-05	0.000243	CbGpPWpGaD
Clodronate—PTGS2—Disease—NOS2—chronic obstructive pulmonary disease	6.86e-05	0.000235	CbGpPWpGaD
Clodronate—PTGS2—Disease—SERPINE1—chronic obstructive pulmonary disease	5.78e-05	0.000198	CbGpPWpGaD
Clodronate—PTGS2—Disease—NOS3—chronic obstructive pulmonary disease	5.52e-05	0.000189	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ALB—chronic obstructive pulmonary disease	4.83e-05	0.000165	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—NOS3—chronic obstructive pulmonary disease	4.62e-05	0.000158	CbGpPWpGaD
Clodronate—PTGS2—Disease—TGFB1—chronic obstructive pulmonary disease	3.65e-05	0.000125	CbGpPWpGaD
Clodronate—PTGS2—Disease—EGFR—chronic obstructive pulmonary disease	3.58e-05	0.000122	CbGpPWpGaD
Clodronate—PTGS2—Disease—IL6—chronic obstructive pulmonary disease	2.75e-05	9.4e-05	CbGpPWpGaD
